|
Withdrawal
On
April 7, 2005 the FDA announced that it has asked Pfizer, Inc.
to withdraw Bextra from the market
"because the overall risk versus benefit profile for the
drug is unfavorable."
Bextra
is included in a class of drugs called COX-2 inhibitors that are
made to stop inflammation and pain from arthritis. It
is also reported to help women who suffer from difficult
menstrual periods.
Side
effects include include heart attack and stroke,
gastrointestinal problems, allergies, respiratory infections and
headaches. The stomach
problems include gastrointestinal bleeding, ulcers, vomiting,
and dark stools. Respiratory problems include infections
of the upper respiratory system.
bextra
has come under fire from the media and some of the medical
community due to studies that have shown that use
of the drug increases the risk of heart attack and stroke by 50%
as opposed to the use of a placebo when used after coronary
artery bypass surgery.
bextra
site map
Scroll
to the bottom of this page to find a lawyer in your state:
http://www.defectivedrugsfyi.com/bextra.html
Autism
Education Materials for early intervention!
|
